Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00121446 | Which Therapy for Acute Heart Attacks? (The WEST Study) | PHASE2 | COMPLETED | 300 | — | — | Jul 1, 2003 | - | May 19, 2017 | 16 | Canada |
| Name | Type | Description |
|---|---|---|
| tenecteplase | DRUG | - |
| enoxaparin | DRUG | - |
| clopidogrel | DRUG | - |
| percutaneous coronary intervention | PROCEDURE | - |
Inclusion Criteria: * Male or non-pregnant female patients aged \>18 years * Patients with symptoms presumed secondary to STEMI lasting at least 20 minutes and accompanied by ECG evidence \>2 mm of ST elevation in 2 or more contiguous precordial leads or in 2 or more limb leads;or \> 1mm ST elevati...